JP2019520407A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019520407A5 JP2019520407A5 JP2019500624A JP2019500624A JP2019520407A5 JP 2019520407 A5 JP2019520407 A5 JP 2019520407A5 JP 2019500624 A JP2019500624 A JP 2019500624A JP 2019500624 A JP2019500624 A JP 2019500624A JP 2019520407 A5 JP2019520407 A5 JP 2019520407A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- cochleates
- cochleate
- cryptococcus
- infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662361351P | 2016-07-12 | 2016-07-12 | |
| US62/361,351 | 2016-07-12 | ||
| US201762513800P | 2017-06-01 | 2017-06-01 | |
| US62/513,800 | 2017-06-01 | ||
| PCT/US2017/041750 WO2018013711A1 (en) | 2016-07-12 | 2017-07-12 | Encochleated antifungal compounds for central nervous system delivery and treatment of cryptococcus infections |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019520407A JP2019520407A (ja) | 2019-07-18 |
| JP2019520407A5 true JP2019520407A5 (https=) | 2020-05-28 |
| JP6991592B2 JP6991592B2 (ja) | 2022-01-12 |
Family
ID=60952715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019500624A Active JP6991592B2 (ja) | 2016-07-12 | 2017-07-12 | 中枢神経系送達のためのコクリエート化抗真菌化合物及びクリプトコッカス感染症の治療 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US11123295B2 (https=) |
| EP (1) | EP3484447A4 (https=) |
| JP (1) | JP6991592B2 (https=) |
| KR (2) | KR20190029642A (https=) |
| CN (2) | CN114053417A (https=) |
| AU (1) | AU2017297402B2 (https=) |
| CA (1) | CA3027668A1 (https=) |
| WO (1) | WO2018013711A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102115718B1 (ko) | 2012-07-30 | 2020-05-28 | 마티나스 바이오파마 나노테크놀로지스, 인코포레이티드 | 대두 포스파티딜세린으로 제조된 코클리에이트 |
| MX2022001871A (es) * | 2019-08-13 | 2022-03-11 | Matinas Biopharma Nanotechnologies Inc | Metodos de tratamiento de las infecciones por criptococo. |
| CN118370831A (zh) * | 2023-01-20 | 2024-07-23 | 中国科学院微生物研究所 | 肌醇磷脂酰胺合成酶抑制剂与两性霉素b的联合用药及其用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000516928A (ja) * | 1996-08-09 | 2000-12-19 | バックマン・ラボラトリーズ・インターナショナル・インコーポレーテッド | 抗真菌性化合物とｎ―アルキル複素環式化合物とを併用する真菌感染の治療 |
| US5837254A (en) | 1996-11-14 | 1998-11-17 | Chen; Yu | Method of treating candida and cryptococcus fungal infections by administering gentian |
| US6153217A (en) | 1999-01-22 | 2000-11-28 | Biodelivery Sciences, Inc. | Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents |
| AUPQ066399A0 (en) | 1999-05-31 | 1999-06-24 | Fujisawa Pharmaceutical Co., Ltd. | Antifungal combination use |
| AU3111401A (en) | 2000-01-24 | 2001-07-31 | Biodelivery Sciences, Inc. | New cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| US20030219473A1 (en) | 2002-03-26 | 2003-11-27 | Leila Zarif | Cochleates made with purified soy phosphatidylserine |
| ES2411961T5 (es) | 2002-11-01 | 2017-04-27 | Rutgers, The State University Of New Jersey | Vehículos de suministro en forma de geoda |
| EP1624858B1 (en) | 2003-04-09 | 2018-06-06 | Rutgers, the State University of New Jersey | Novel encochleation methods |
| WO2004092123A2 (en) * | 2003-04-10 | 2004-10-28 | Microbia, Inc. | Inhibitors of fungal invasion |
| CN105168250B (zh) * | 2004-10-25 | 2019-02-05 | 塞勒兰特治疗公司 | 增殖骨髓细胞群体的方法及其应用 |
| JP5216323B2 (ja) * | 2005-04-07 | 2013-06-19 | 富山化学工業株式会社 | 医薬組成物および抗真菌剤を組み合わせて使用する方法 |
| CN101304757A (zh) * | 2005-06-29 | 2008-11-12 | 纽约州立大学研究基金会 | 免疫原性较低的蛋白质-脂质复合物的组合物和方法 |
| WO2009006311A2 (en) * | 2007-06-29 | 2009-01-08 | Wisconsin Alumni Research Foundation | Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals |
| DE102008054431B3 (de) * | 2008-12-09 | 2010-06-17 | Pari Pharma Gmbh | Aerosoltherapievorrichtung |
| WO2010091090A1 (en) * | 2009-02-03 | 2010-08-12 | Biodelivery Sciences International, Inc. | Cochleate compositions and methods of use |
| EP2704688B1 (en) | 2011-05-05 | 2019-07-10 | Matinas BioPharma Nanotechnologies, Inc. | Cochleate compositions and methods of making and using same |
| KR102115718B1 (ko) | 2012-07-30 | 2020-05-28 | 마티나스 바이오파마 나노테크놀로지스, 인코포레이티드 | 대두 포스파티딜세린으로 제조된 코클리에이트 |
-
2017
- 2017-07-12 CA CA3027668A patent/CA3027668A1/en active Pending
- 2017-07-12 EP EP17828400.6A patent/EP3484447A4/en not_active Ceased
- 2017-07-12 CN CN202111352284.7A patent/CN114053417A/zh active Pending
- 2017-07-12 CN CN201780056037.8A patent/CN109689028A/zh active Pending
- 2017-07-12 JP JP2019500624A patent/JP6991592B2/ja active Active
- 2017-07-12 KR KR1020197003873A patent/KR20190029642A/ko not_active Ceased
- 2017-07-12 WO PCT/US2017/041750 patent/WO2018013711A1/en not_active Ceased
- 2017-07-12 US US16/312,047 patent/US11123295B2/en active Active
- 2017-07-12 AU AU2017297402A patent/AU2017297402B2/en active Active
- 2017-07-12 KR KR1020227041763A patent/KR20230003167A/ko not_active Ceased
-
2021
- 2021-08-31 US US17/463,021 patent/US20210393526A1/en not_active Abandoned
-
2024
- 2024-07-09 US US18/767,226 patent/US20240423916A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022003102A (es) | Degradadores bifuncionales de brd9 y sus metodos de uso. | |
| MX2016010213A (es) | Formulaciones farmaceuticas novedosas. | |
| MX393855B (es) | Terapia de combinación que comprende un inhibidor de raf y trametinib | |
| BR112017010439A2 (pt) | composto, composição farmacêutica, combinação farmacêutica, kit, métodos para controle de uma doença fúngica em uma planta e para prevenção ou tratamento de doença fúngica em um indivíduo, e, uso de um composto | |
| MY199968A (en) | Formulations of an lsd1 inhibitor | |
| JP2018021046A5 (https=) | ||
| WO2020115555A3 (en) | Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia | |
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| JP2016528301A5 (https=) | ||
| MX2014000341A (es) | Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades. | |
| MX2017010287A (es) | Composiciones farmaceuticas que comprenden n-(3,5-dimetoxifenil)-n '-(1-metiletil)-n-[3-(1-metil-1h-pirazol-4-il)quinoxalin-6-il]eta no-1,2-diamina. | |
| NZ708593A (en) | Novel pyrazole derivative | |
| BR112016022598A8 (pt) | composição aerossol farmacêutica na forma de um pó seco para liberação pulmonar, forma de dosagem unitária, pacote farmacêutico, kit e uso | |
| WO2016109217A3 (en) | Btk inhibitors | |
| EA033448B1 (ru) | Композиция орлистата и акарбозы с модифицированным высвобождением для лечения ожирения и связанных метаболических нарушений | |
| MY163235A (en) | Pharmaceutical preparation containing pyridylaminoacetic acid compound | |
| NZ721500A (en) | Use of halogen compounds for the treatment and prevention of heart attack and ischemic injury | |
| EA201891931A1 (ru) | Новые ингибиторы фосфатидилинозитол-3-киназы гамма | |
| JP2015502926A5 (https=) | ||
| HK1217495A1 (zh) | 治疗活性的作为17β-羟基类固醇脱氢酶抑制剂的17-氮取代雌三烯噻唑衍生物 | |
| JP2019520407A5 (https=) | ||
| PH12020552274A1 (en) | Formulations of an axl/mer inhibitor | |
| CN109689652A (zh) | 稠杂环类衍生物、其制备方法及其在医学上的应用 | |
| WO2017134685A3 (en) | Novel hydrazino compounds as btk inhibitors | |
| JP2020529995A5 (https=) |